Home » Authors » Trista Morrison

Articles by Trista Morrison

Elixir Raises $46M Series C For Metabolic Disease Trials

Nov. 29, 2006

By Trista Morrison

Orexigen Closes $30M Round For Late-Stage Obesity Trials

Nov. 27, 2006

By Trista Morrison

Orexigen Closes $30M Round For Late-Stage Obesity Trials

Nov. 27, 2006

By Trista Morrison

Intradigm Raises $16M For Systemic Delivery Of RNAi

Nov. 22, 2006

By Trista Morrison

Intradigm Raises $16M For Systemic Delivery Of RNAi

Nov. 22, 2006

By Trista Morrison

Neurotech Brings In $35M For Phase II Retinal Disease Trials

Nov. 17, 2006

By Trista Morrison

Neurotech Brings In $35M For Phase II Retinal Disease Trials

Nov. 17, 2006

By Trista Morrison

Biotech's Business Models Evolve As Industry Matures

Nov. 16, 2006

By Trista Morrison

Biotech's Business Models Evolve As Industry Matures

Nov. 16, 2006

By Trista Morrison

Sofinnova Closes $375M Fund To Support Spinouts

Nov. 15, 2006

By Trista Morrison

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for May 9, 2025.
100 days of uncertainty
BioWorld
The first 100 days of the Trump administration have been nothing short of chaotic, both in the U.S. and throughout the world. Shining a light through the...
AACR 2025: Induced proximity strategy, beyond degraders
BioWorld
Targeted protein degradation has yet to notch its first approval. But with more than two dozen agents now in clinical trials, the strategy’s ultimate clinical...
NME Digest: Q1 2025
BioWorld
A quarterly dynamic table featuring new molecular entities (NMEs) revealed for the first time in current literature, at congresses and in company communications...